department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Alprazolam · pharmadog

pharmadog
drugs
Alprazolam

drug

patient view →

alprazolam ER

Marketedupdated 2mo ago

by $AMRX Amneal Pharmaceuticals, Inc.

Approved

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 7 investigational indications.

indications

investigational

EpilepsyMajor Depression

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Alprazolam

generic

alprazolam

MOA

GABA-A receptor; anion channel positive allosteric modulator

indication

Panic Disorders

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying alprazolam ER

phase3A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizuresrecruitingn=350
phase3A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizuresenrolling by invitationn=300
phase1Staccato Alprazolam Abuse Liabilitycompletedn=31
phase2Staccato Alprazolam and Photoparoxysmal Responsecompletedn=5
phase1A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participantscompletedn=55
phase1A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experiencecompletedn=100
phase1A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Userscompletedn=53
phase1Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditionscompletedn=32

more trials →